An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...] …
Articles by : Bella Czajkowski, National Correspondent
Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...] …
Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...] …
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...] …
A key federal court decision to uphold Louisiana’s contact pharmacy law this week is drawing praise from provider groups and [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Eligible providers in Florida and North Carolina can now enroll in the 340B program outside of the formal enrollment period [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …